Sunday, September 27, 2026

Boston Scientific Stock Rises 3% As Session Comes To An End On Tuesday, Outperforms Market

ViaNews Editorial Team

December 15, 2020

Boston Scientific Stock Rises 3%  As Session Comes To An End On Tuesday, Outperforms Market

Shares of Boston Scientific jumped 3.45% to $34.60 at 15:35 EST on Tuesday, after three successive sessions in a row of losses. The New York Stock Exchange is rising 1.26% to $14,394.10, after two consecutive sessions in a row of losses. This seems, at the moment, an all-around positive trend exchanging session today.

Boston Scientific's last close was $33.45, 34.74% below its 52-week high of $46.62.

Boston Scientific's Sales

Boston Scientific's sales growth is a negative 0.7% for the present quarter and 9.3% for the next. The company's growth estimates for the present quarter is a negative 30.4% and positive 28.6% for the next.

Boston Scientific's Revenue

Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 10.11B for the twelve trailing months.

Boston Scientific's Stock Top and Bottom Yearly Value

Boston Scientific's stock is valued at $34.60 at 15:35 EST, way below its 52-week high of $46.62 and way higher than its 52-week low of $24.10.

Boston Scientific's Moving Average

Boston Scientific's value is under its 50-day moving average of $34.89 and below its 200-day moving average of $37.34.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com